Senate approves women's screening amendment in first health bill vote

NewsGuard 100/100 Score

The Associated Press: The Senate voted 61-39 Thursday "to safeguard coverage of mammograms and preventive screening tests for women under any health care overhaul legislation." The revision, which was advanced by Sen. Barbara Mikulski, D-Md., Sen. Olympia Snowe, R-Maine, "would allow the Health and Human Services secretary to require insurers to cover preventive health screenings free of charge" (Alonso-Zaldivar, 12/3).

"The Republican senators voting in favor were the two women from Maine, Olympia J. Snowe and Susan Collins, and Senator David Vitter of Louisiana. Among Democrats, Senators Russ Feingold of Wisconsin and Ben Nelson of Nebraska opposed the proposal," according to New York Times' Prescriptions. "The vote on Ms. Mikulski's amendment broke an impasse between Democrats and Republicans over when to begin voting on amendments to the health care legislation. ... Under an agreement reached on Wednesday night, two additional votes are scheduled for Thursday and the amendment process finally seems to be shifting into gear. But tensions are running high at the Capitol, and further procedural disputes are inevitable." This vote "broke an impasse between Democrats and Republicans over when to begin voting on amendments to the health care legislation. ... Under an agreement reached on Wednesday night, two additional votes are scheduled for Thursday and the amendment process finally seems to be shifting into gear" (Herszenhorn and Pear, 12/3). 

Reuters: Today's vote "follows last month's controversy over federal task force recommendations that women delay regular mammograms for breast cancer and from a doctor's group that women delay pap smears for cervical cancer. On a 59-41 vote, the Senate rejected a companion Republican amendment to ensure the task force recommendations could be ignored, which Democrats said was 'too tepid' and would not remove cost barriers to screenings" (Whitesides, 12/3).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
First FDA-approved cellular therapy for metastatic melanoma available in South Florida